The economics of prescribing.
作者信息
Jennings M
机构信息
Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield.
出版信息
J R Coll Physicians Lond. 1992 Jan;26(1):66-8.
Abstract
摘要
相似文献
1
The economics of prescribing.处方经济学
J R Coll Physicians Lond. 1992 Jan;26(1):66-8.
2
How to pay for expensive drugs.如何支付昂贵的药物费用。
BMJ. 1991 Sep 14;303(6803):593-4. doi: 10.1136/bmj.303.6803.593.
3
Therapeutic conservatism: more costly in the long term? A UK perspective.治疗保守主义：从长远来看成本更高？英国视角。
Pharmacoeconomics. 1995 May;7(5):378-87. doi: 10.2165/00019053-199507050-00002.
4
Pharmacist-physician drug fair for educating physicians in cost-effective prescribing.药剂师-医生药品交流会，旨在培训医生进行经济高效的处方开具。
Am J Hosp Pharm. 1993 Oct;50(10):2088-9.
5
'Appropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?
Appl Health Econ Health Policy. 2017 Feb;15(1):1-3. doi: 10.1007/s40258-016-0240-7.
6
A UK national prescribing list?
Pharmacoeconomics. 1995 Jun;7(6):471-4. doi: 10.2165/00019053-199507060-00001.
7
Efficiency-based pharmacotherapy: the new paradigm for the 21st century in medicine.
Eur J Clin Pharmacol. 2000 Nov;56(8):525-7. doi: 10.1007/s002280000193.
8
[Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].[医学专家组与药物选择。公平的优先排序过程可确保药物选择的可靠性]
Lakartidningen. 2004 Aug 5;101(32-33):2480-2, 2484.
9
Cost-cutting ideas: prescription drugs.削减成本的思路：处方药。
J Health Care Benefits. 1993 Sep-Oct;3(1):10-3.
10
Geriatric pharmacology, Special features of geriatric prescribing.
Geriatrics. 1981 Dec;36(12):41-52.
引用本文的文献
1
Economic constraints and prescribing patterns in New Zealand.
Pharmacoeconomics. 1992 Sep;2(3):189-97. doi: 10.2165/00019053-199202030-00002.
本文引用的文献
1
Review of clinical budgeting and costing experiments.
Br Med J (Clin Res Ed). 1983 Feb 12;286(6364):575-8. doi: 10.1136/bmj.286.6364.575.
2
A year's experience of functional budgeting in a clinical department.
Anaesthesia. 1981 Mar;36(3):316-8. doi: 10.1111/j.1365-2044.1981.tb10210.x.
3
The end of clinical freedom.临床自由的终结。
Br Med J (Clin Res Ed). 1983 Oct 29;287(6401):1237-8. doi: 10.1136/bmj.287.6401.1237.
4
Economic consequences of postinfarction prophylaxis with beta blockers: cost effectiveness of metoprolol.β受体阻滞剂用于心肌梗死后预防的经济后果：美托洛尔的成本效益
Br Med J (Clin Res Ed). 1987 Feb 7;294(6568):339-42. doi: 10.1136/bmj.294.6568.339.
5
Treatment of high blood pressure: should clinical practice be based on results of clinical trials?高血压的治疗：临床实践应基于临床试验结果吗？
Br Med J (Clin Res Ed). 1986 Aug 16;293(6544):433-7. doi: 10.1136/bmj.293.6544.433.
6
Carboplatin versus cisplatin.卡铂与顺铂对比
Lancet. 1988 Dec 10;2(8624):1372-3. doi: 10.1016/s0140-6736(88)90917-8.
7
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.17187例疑似急性心肌梗死患者静脉注射链激酶、口服阿司匹林、两者并用或两者均不用的随机试验：ISIS-2。ISIS-2（第二次心肌梗死存活国际研究）协作组
Lancet. 1988 Aug 13;2(8607):349-60.
8
Balancing cost and benefit in treatment of late cancer.晚期癌症治疗中的成本效益平衡
Lancet. 1988 Mar 12;1(8585):579-80.
9
The influence of relapse rate on the choice of duodenal ulcer therapy.复发率对十二指肠溃疡治疗选择的影响。
Drug Ther Bull. 1987 Oct 5;25(20):77-80.
Zotero 插件